Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054606 | 1.00 | FAAH (0.46) | FAAHALOX15SMN1; SMN2SLC6A5MAPK1 | |
| SCHEMBL290509 | 1.00 | FAAH (0.46) | FAAHALOX15SMN1; SMN2SLC6A5MAPK1 | |
| SCHEMBL10992067 | 0.98 | FAAH (0.45) | FAAHALOX15SMN1; SMN2SLC6A5MAPK1 | |
| SCHEMBL2114688 | 0.93 | SMN1; SMN2 (0.49) | FAAHSMN1; SMN2SLC6A5EPHX1ACE2 | |
| SCHEMBL171001 | 0.93 | SMN1; SMN2 (0.49) | FAAHSMN1; SMN2SLC6A5EPHX1ACE2 | |
| SCHEMBL171002 | 0.93 | SMN1; SMN2 (0.49) | FAAHSMN1; SMN2SLC6A5EPHX1ACE2 | |
| SCHEMBL10579468 | 0.91 | EPHX1 (0.48) | FAAHSMN1; SMN2EPHX1ACE2GPR84 | |
| SCHEMBL10631088 | 0.91 | EPHX1 (0.48) | FAAHSMN1; SMN2EPHX1ACE2GPR84 | |
| SCHEMBL352163 | 0.91 | EPHX1 (0.48) | FAAHSMN1; SMN2EPHX1ACE2GPR84 | |
| SCHEMBL22325587 | 0.91 | EPHX1 (0.48) | FAAHSMN1; SMN2EPHX1ACE2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 916 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4274838-B1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS | BICYCLETX LTD (GB) | 2024-09-25 | — | — | EP | claimed |
| EP-3752174-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | University of Florida Research Foundation, Incorporated (US) | 2020-12-23 | — | — | EP | claimed |
| WO-2019160910-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2019-08-22 | — | — | WO | claimed |
| EP-3271330-A1 | IMPROVED PROCESS FOR THE PREPARATION OF APREMILAST | Cipla Limited (IN) | 2018-01-24 | — | — | EP | claimed |
| WO-2016146990-A1 | IMPROVED PROCESS FOR THE PREPARATION OF APREMILAST | CIPLA LIMITED (IN) | 2016-09-22 | — | — | WO | claimed |
| EP-2752423-A2 | GPCR ligands and method of using same | Compugen Ltd. (IL) | 2014-07-09 | — | — | EP | claimed |
| US-20120129776-A1 | Bioactive peptides and method of using same | COMPUGEN LTD. (IL) | 2012-05-24 | — | — | US | claimed |
| EP-2064234-B1 | BIOACTIVE PEPTIDES AND METHOD OF USING SAME | COMPUGEN LTD (IL) | 2011-11-02 | — | — | EP | claimed |
| EP-2167534-A2 | BIOACTIVE PEPTIDES AND METHOD OF USING SAME | Compugen Ltd. (IL) | 2010-03-31 | — | — | EP | claimed |
| EP-2064234-A2 | BIOACTIVE PEPTIDES AND METHOD OF USING SAME | Compugen Ltd. (IL) | 2009-06-03 | — | — | EP | claimed |
| WO-2009019531-A2 | BIOACTIVE PEPTIDES AND METHOD OF USING SAME | COMPUGEN LTD (IL) | 2009-02-12 | — | — | WO | claimed |
| WO-2009007848-A2 | BIOACTIVE PEPTIDES AND METHOD OF USING SAME | COMPUGEN LTD. (IL) | 2009-01-15 | — | — | WO | claimed |
| US-6858585-B1 | Cyclic depsipeptides and drugs containing the same as the active ingredient | NISSHIN SEIFUN GROUP INC. (JP) | 2005-02-22 | — | — | US | claimed |
| US-4405578-A | CARBON DIOXIDE, ABSORPTION | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-09-20 | — | — | US | claimed |
| EP-0079767-A2 | Amino acids and a process for preparing same | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-05-25 | — | — | EP | claimed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-4376102-A | AMINO ACID AS COSOLVENT | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-03-08 | — | — | US | disclosed |
| US-4376101-A | Process for removing acid gases using a basic salt activated with a non-sterically hindered diamine | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-03-08 | — | — | US | disclosed |
| US-4069385-A | FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |